Latest investigations into retatritide peptide demonstrate significant potential for treating obesity and non-insulin dependent disease. The compound, a dual agonist of GLP-1 and glucose-dependent insulinotropic polypeptide, seems to offer enhanced weight reduction and glucose regulation in contr